Sirolimus (Rapamune)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Sirolimus (Rapamune), covering 2012-01-31 to 2026-01-16. Get the full timeline:
Most recent: Clinical Trial Update: Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy [Phase 2]